News

View: 

Jayasree K. Iyer to chair panel on barriers to NCDs in sub-Saharan Africa

24 August 2016 |
On 26 August in Nairobi, Jayasree K. Iyer, Executive Director of the Access to Medicine Foundation, will chair a panel at TICAD VI of experts, discussing the challenge of treating non-communicable diseases in sub-Saharan Africa.› Read more

Shifting mindsets to improve access to medicine

2 August 2016 |
What levers need to be pulled to improve access to medicine worldwide? Jayasree K. Iyer, Executive Director, shares ideas that would lead to more people accessing the medicine they need. › Read more

2016 Access to Medicine Index: out in November

8 July 2016 |
The Access to Medicine Foundation is preparing a new iteration of its leading sustainability Index of pharmaceutical companies – the next Access to Medicine Index will be published in November 2016.› Read more

Now online: Going beyond CSR to reach ‘the two billion’ by Jayasree K. Iyer for PharmaPhorum

1 July 2016 |
Writing on PharmaPhorum, Jayasree K. Iyer, Executive Director of the Access to Medicine Foundation, shows how pharma companies are taking access to medicine beyond CSR, and putting it at the core of their businesses.› Read more

Access to Vaccines Index: the data is in, analysis can begin

10 June 2016 |
The Access to Vaccines Index will analyse how vaccine companies are improving access to high-priority vaccines for communities in need. The Foundation’s research team can now begin analysing companies’ vaccine data against developments in the vaccines landscape.› Read more

Ongoing dialogue: with Japanese pharma industry and at OECD Responsible Business Forum

3 June 2016 |
From June 6–9, Executive Director, Jayasree K. Iyer, will be in Tokyo to follow up on the Foundation’s recent dialogue with Japanese pharmaceutical companies, and to meet with representatives of Japanese Government Ministries. › Read more

The Access to Medicine Foundation at the 69th WHO World Health Assembly

20 May 2016 |
The WHO’s annual World Health Assembly (WHA) draws the greatest minds working on global health. This year, Jayasree K. Iyer, Executive Director, together with Research Programme Manager Tara Prasad, will be joining on behalf of the Access to Medicine Foundation.› Read more

Data collection in progress for the 2016 Access to Medicine Index

26 April 2016 |
The world’s top 20 pharmaceutical companies are now submitting data for the 2016 Access to Medicine Index, on the measures they are taking to improve access to medicine. The 2016 Index will explore how companies are shifting from commitment-making to action-taking when it comes to ensuring medicines and vaccines are within the reach of the world’s global poor.› Read more

How the Access to Medicine Index inspires stronger action by pharma companies

9 March 2016 |
An Independent Impact Evaluation concludes that the Access to Medicine Index is a catalyst and inspiration for pharma companies to do more for the two billion people who lack access to medicine. › Read more

Access to Medicine Foundation presenting to the UN High-Level Panel on Access to Medicines

8 March 2016 |
On 9 and 10 March 2016, Damiano de Felice and Danny Edwards will be in London to present the work of the Access to Medicine Foundation at the public hearing and global dialogue hosted by the United Nations Secretary-General High-Level Panel on Access to Medicines.› Read more

Dialogue on Access to Medicine with Japanese pharma companies

8 January 2016 |
The Access to Medicine Foundation will be visiting Tokyo, Japan for a series of meetings with Japan-based pharmaceutical companies and other key stakeholders working towards improving access to medicine worldwide.› Read more

A new catalyst for change: methodology for the first Access to Vaccines Index

1 December 2015 |
The Access to Medicine Foundation is introducing a new tool for action – the Access to Vaccines Index. It will analyse how vaccine companies are improving access to high-priority vaccines for communities in need. › Read more

The Bulletin of WHO publishes an article on the thematic study: hepatitis C by the Access to Medicine Foundation

24 November 2015 |
The Bulletin of the World Health Organization has published the latest study from the Access to Medicine Foundation: on how the world’s largest pharma companies are improving access to hepatitis C treatment. These companies have an opportunity to play a central role in curbing, and perhaps ending, a global epidemic.› Read more

Pharmaceutical companies come to Amsterdam: workshop on latest Index methodology

17 November 2015 |
On 18 and 19 November, the Access to Medicine Foundation will run a workshop in Amsterdam for 20 of the world’s largest pharmaceutical companies with a role to play in improving access to medicine. Over 40 company representatives are coming to Amsterdam for the workshop, from across Europe, Japan and the US.› Read more

2016 Access to Medicine Index to place high emphasis on how pharmaceutical companies perform

29 October 2015 |
The Access to Medicine Foundation has published its latest methodology for benchmarking pharma companies on their efforts to improve access to medicine. The methodology for the 2016 Access to Medicine Index places greater emphasis on company performance.› Read more

Jayasree K. Iyer becomes Executive Director of the Access to Medicine Foundation

21 October 2015 |
As of October, 2015, Jayasree K. Iyer is Executive Director of the Access to Medicine Foundation, taking over from Wim Leereveld. Wim Leereveld will join the Foundation’s Supervisory Board.› Read more

New Research: promising vaccine candidates and persistent R&D gaps

30 September 2015 |
A new study by the Access to Medicine Foundation identifies promise in the vaccine pipeline from the world’s largest pharmaceutical companies. Certain vaccine candidates are clearly supported by plans for facilitating their future accessibility, yet such planning ahead for access does not appear to be consistent or widespread.› Read more

Coming up: speaking engagements & events – open invitation

11 September 2015 |
Come and join Wim Leereveld, CEO, and Jayasree K. Iyer, Head of Research, from the Access to Medicine Foundation, at a series of public events In the coming weeks to discuss access to medicine and the role for pharmaceutical companies.› Read more

Consensus emerges on approach for improving access to vaccines

3 September 2015 |
After talking to vaccine stakeholders, the Access to Medicine Foundation is now crystallising consensus on how vaccine companies can best approach access to vaccines. This is integral to the finalisation of metrics for the first Access to Vaccines Index.› Read more

Catch-up: How do pharma companies support MDG5?

24 June 2015 |
Catch-up with the web discussion co-convened by the Access to Medicine Foundation, the UN Foundation and Family Planning 2020 about how pharmaceutical companies’ are improving access to maternal health and contraception. The discussion centers on a landscape study recently published by the Access to Medicine Foundation. › Read more

2015 Methodology Review: independent experts meet to evaluate next Index methodology

16 June 2015 |
On 17 June, the Expert Review Committee will gather in Haarlem to review key methodology proposals for the next Access to Medicine Index and the first Access to Vaccines Index.› Read more

2015 Methodology Review: targeting key aspects of the Index analysis

13 May 2015 |
The Access to Medicine Foundation is now reviewing the Index methodology in preparation for the next Access to Medicine Index. With stakeholder engagement as a central pillar, the 2015 Methodology Review focuses on key aspects of the Index analysis. › Read more

Access to Vaccines Index: introducing the first principles

12 May 2015 |
The Access to Medicine Foundation has started the development of a new Index, focused exclusively on vaccines. It will measure and compare the efforts of vaccine manufacturers to make vaccines accessible for people living in developing countries.› Read more

New Research: How pharmaceutical companies address access to maternal and reproductive health

9 April 2015 |
Every day, an estimated 800 women die during pregnancy and childbirth due to preventable causes. Today, the Access to Medicine Foundation publishes the first landscape study of pharmaceutical companies’ responses to MDG 5 to help improve this situation.› Read more

April 9: WHO seminar on Access to Medicine Index; BioPharma Sustainability Roundtable

31 March 2015 |
In April, representatives of the Access to Medicine Foundation have been invited to lead a WHO seminar in Geneva and speak at the BioPharma Sustainability Roundtable in Cambridge, USA.› Read more

Pharma companies discuss 2014 Index performances

10 February 2015 |
The 2014 Access to Medicine Index identifies clear opportunities for pharmaceutical companies to improve access to their products. During a month of individual evaluation sessions, companies and the Index team discuss how to make the most of their potential.› Read more

Access to Medicine Index receives funds from the Postcode Loterij

27 January 2015 |
The Postcode Loterij in the Netherlands has awarded one of its 2015 annual grants to the Access to Medicine Foundation. The cheque was presented at the Postcode Loterij’s annual ‘Goed Geld Gala’ event in Amsterdam on 26 January.› Read more

Recap: launch of the 2014 Access to Medicine Index

25 January 2015 |
Since publication, the 2014 Access to Medicine Index has been discussed widely in the media, at events and in one-on-one meetings with stakeholders. This article recaps these activities and sets out where to find out more.› Read more

2014 Access to Medicine Index at the European Parliament – open invitation

22 January 2015 |
On 4 February, the 2014 Access to Medicine Index will be launched at the European Parliament in Brussels. Index Head of Research, Jayasree K. Iyer, will present the latest ranking of the top 20 global pharmaceutical companies.› Read more

Davos 2015: Wim Leereveld on health systems design

19 January 2015 |
On January 22, during the World Economic Forum Annual Meeting, Index CEO and founder Wim Leereveld will be in Davos to discuss the strategic design of health systems, including how to select, incubate and scale up those initiatives that hold the most promise. › Read more

Inside the 2014 Access to Medicine Index investor meetings

20 December 2014 |
In the weeks following the publication of the 2014 Access to Medicine Index, four investor meetings about the new Index took place: in London, Paris, Basel and New York City. Here we provide an overview of the central themes of discussion at these events.› Read more

Licensing medicines for HIV/AIDS: critical mechanism for ending the epidemic

1 December 2014 |
For World Aids Day, the Access to Medicine Index has analysed the licensing practices of the top 20 research-based pharmaceutical companies to assess how they are contributing to global efforts to combat HIV/AIDS.› Read more

2014 Access to Medicine Index – More being done, but progress is uneven

17 November 2014 |
The world’s leading pharmaceutical companies are doing more to improve access to medicine in developing countries, with a raft of new initiatives, scale-ups and innovations over the last two years. However, the industry struggles to perform well in some practices that matter, according to the 2014 Access to Medicine Index, published Monday.› Read more

2014 Access to Medicine Index – to be published November 17

15 October 2014 |
“We have the clearest ever picture of how the pharmaceutical industry is performing, and a deeper understanding of what it takes to be a leader,” Wim Leereveld, Index CEO and Founder.› Read more

Investor meetings – 2014 Index in London, Paris, Basel, NYC

15 October 2014 |
Following its launch, the 2014 Access to Medicine Index will be presented to investors and other stakeholders at a series of meetings, hosted by Aviva Investors, Amundi Asset Management, Bank J. Safra Sarasin and Boston Common Asset Management.› Read more

Deutsche Bank draws on Access to Medicine Index for pharma analysis

23 September 2014 |
Titled “Tropical diseases; social responsibility, neglected market”, the new Deutsche Bank Markets Research report draws significantly on the 2012 Access to Medicine Index.› Read more

Wim Leereveld to address WHO, WIPO, WTO symposium

1 September 2014 |
The symposium will take place on 5 November 2014 in Geneva, and will be opened by the Directors-General of the WHO, WIPO and WTO. Index Founder Wim Leereveld will address the changing role of pharmaceutical companies.› Read more

Joep Lange will be greatly missed

18 July 2014 |
We were deeply saddened to learn that HIV pioneer Joep Lange died in the aircrash above Ukraine on 17 July. Joep Lange was a member of the Foundation’s Advisory Committee. He was one of the earliest supporters of the Access to Medicine Foundation, and remained always ready to lend his strength and advice. His commitment to improving global health was almost unmatched.› Read more

2014 Index: point-by-point analysis begins

17 June 2014 |
The analysis at the heart of the 2014 Access to Medicine Index has begun: the Index team is now conducting a point-by-point comparison of companies’ performances, policies and practices for improving access to medicine.› Read more

Data-collection update: clarification has begun

9 April 2014 |
Data-collection for the 2014 Access to Medicine Index has entered the next stage: following a detailed evaluation of the data by the analysts, the 21 pharmaceutical companies have started clarifying and supplementing their information. Head of Research, Jayasree K. Iyer explains further.› Read more

R&D for TB: medicines against drug-resistant TB is the main focus for big pharma

22 March 2014 |
Nine million people suffer from TB, and three million TB patients have no access to treatment. For World TB Day, the Access to Medicine Index analysed data from the 2012 Index and public sources to see where the 20 largest pharmaceutical companies are focusing their clinical-trial efforts to tackle this disease: on new TB vaccines and drugs, and on drug-resistant strains of TB.› Read more

Access to Medicine Index in world's 3 most credible sustainability ratings

18 February 2014 |
In the 2013 Polling the Experts survey by GlobeScan/SustainAbility, experts have placed the Access to Medicine Index in the three most credible sustainability ratings worldwide.› Read more

The Lancet Global Health publishes longitudinal analysis

31 January 2014 |
In a letter published today in The Lancet Global Health, Professor Hans Hogerzeil and members of the Foundation's Research Team set out the method and findings of the first longitudinal analysis based on the Access to Medicine Index.› Read more

Ten years on, the role for the Index continues to grow

28 January 2014 |
It is ten years since work began on the first Access to Medicine Index. To mark this milestone, the Foundation brought together many of the people who helped make the Index a reality. Held on 23 January, the event provided a timely opportunity to assess the path ahead for the Index.› Read more

Data collection starts for the 2014 Access to Medicine Index

13 January 2014 |
Today marks the start of the data collection process for the 2014 Access to Medicine Index. Over the next few months, pharmaceutical companies will submit their data using our online platform, which is set up to ensure that the data is as concise, relevant and of the highest quality possible.› Read more

Seasons Greetings!

17 December 2013 |
A lively year of engagement with various stakeholders has passed, leading to our revised methodology and a fresh eye on 2014. We now turn our focus to the 2014 Access to Medicine Index, preparing for data submission by the 21 companies, as well developing other features of the Index.› Read more

Access to Medicine Index places more emphasis on how well pharmaceutical companies respond to patient needs

12 November 2013 |
- Refined methodology to measure Big Pharma's initiatives in more countries for more diseases -› Read more

Sustainalytics named 2014 Access to Medicine Index Research Partner

1 October 2013 |
The Access to Medicine Foundation has selected Sustainalytics as its research partner for the 2014 Access to Medicine Index. Following a competitive tender process, Sustainalytics emerged as the top candidate due to the firm’s expertise in environmental, social and governance (ESG) research and analysis and its dedicated pharmaceutical industry analysts.› Read more

New England Journal of Medicine publishes Index Perspective article

5 September 2013 |
Today, the New England Journal of Medicine is publishing a Perspective article written by Hans Hogerzeil. The article sets out the methods of the Access to Medicine Index, touching upon the 2012 Index’ key findings and trends.› Read more

BNP Paribas becomes newest Index signatory investor

13 August 2013 |
BNP Paribas Investment Partners, one of Europe’s largest investment groups with €503 billion in assets under management and advice, is the latest addition to the group of investors supporting the Access to Medicine Index.› Read more

Pages

You are here